Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 39365960

Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2025 Jan 20
First author
Phillips TJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Phillips TJ
      type
      Author
    2. name
      Carlo-Stella C
      type
      Author
    3. name
      Morschhauser F
      type
      Author
    4. name
      Bachy E
      type
      Author
    5. name
      Crump M
      type
      Author
    6. name
      Trněný M
      type
      Author
    7. name
      Bartlett NL
      type
      Author
    8. name
      Zaucha J
      type
      Author
    9. name
      Wrobel T
      type
      Author
    10. name
      Offner F
      type
      Author
    11. name
      Humphrey K
      type
      Author
    12. name
      Relf J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Phillips TJ
      type
      Author
    2. name
      Carlo-Stella C
      type
      Author
    3. name
      Morschhauser F
      type
      Author
    4. name
      Bachy E
      type
      Author
    5. name
      Crump M
      type
      Author
    6. name
      Trněný M
      type
      Author
    7. name
      Bartlett NL
      type
      Author
    8. name
      Zaucha J
      type
      Author
    9. name
      Wrobel T
      type
      Author
    10. name
      Offner F
      type
      Author
    11. name
      Humphrey K
      type
      Author
    12. name
      Relf J
      type
      Author
    bibliography ids
    1. nci-bib-b61cae4a211d81c353c9a830
    book metadata
    content sha256
    21a90fc2c9f8e3a8fcc6f11ea893b39b4d63b9e2fdb14796f9a740e63051fc1e
    document type
    citation
    dois
    1. 10.1200/JCO.23.02470
    electronic publication date
    display
    2024 Oct 4
    precision
    day
    year
    2024
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:39365960
    immutable id
    pubmed:39365960@21a90fc2c9f8e3a8fcc6f11ea893b39b4d63b9e2fdb14796f9a740e63051fc1e
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    3
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    318-328
    volume
    43
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      39365960
      provenance
      batch id
      3e43afde6f26fc8df6da
      provider
      NCBI PubMed ESummary
      record sha256
      517f457ce2ff4a9654b834a7fd5542a64cfa02f5600c8f9f8d703a9539d4a875
      response sha256
      fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
      retrieved at
      2026-09-09T23:48:21.145285+00:00
      publication date
      display
      2025 Jan 20
      precision
      day
      year
      2025
      publication types
      1. Journal Article
      2. Clinical Trial, Phase II
      3. Clinical Trial, Phase I
      4. Multicenter Study
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/39365960/
      title
      Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study.

      Preserved source evidence · Not medical advice